News – Page 706 – Endpoints News

Roche, Bristol Myers, and Merck prep defense for 6 ‘dangling’ PD-(L)1 accelerated approvals, even though they ...

5 years ago

J&J's Tremfya scores 5-year psoriasis win in AAD data dump; Roche, Regeneron drugs among latest to earn EU advisory ...

5 years ago

Shorla Pharma scores an expedited review for its mystery candidate to treat T-cell malignancies

5 years ago

A pair of Bayer execs land promotions in the US; Energized by lenzilumab data, Humanigen taps AstraZeneca alum as CMO

5 years ago

Inovio's Covid-19 vaccine studies just hit a brick wall at the Pentagon. Are other hopefuls in trouble?

5 years ago

How the SCOTUS decision to gut the FTC could help biopharma companies

5 years ago

Bristol Myers' next-gen immunology med busts Amgen's Otezla in head-to-head study. Is a showdown coming?

5 years ago

With new PhIII data in hand, Dermavant lines up topical psoriasis contender for a sprint to the finish line

5 years ago

With 7 PD-(L)1s on the market, price competition hasn't been a factor. Will Regeneron be the first to ask for less?

5 years ago

Oxford and Novavax tout 75%+ efficacy for malaria vaccine, besting GlaxoSmithKline in long hunt to inoculate against ...

5 years ago

April showers bring more biotechs to Nasdaq, as Rain and Impel bump 2021's total raise above $6B

5 years ago

Covid-19 roundup: EMA ups Pfizer, Moderna vaccine manufacturing capabilities amid shortage

5 years ago

GlaxoSmithKline hustles the 7th PD-1 past the finish line with Jemperli. But how big will uptake be?

5 years ago

JP Gabriel watched from the bleachers as the pandemic raged. Now head of supply chain at Ocugen, he's ready to bat

5 years ago

Senators to NIH: Do more to protect US biomedical research from foreign influence

5 years ago

Covid-19 manufacturing roundup: Maryland looks to grow biotech capacity with $400M check; Russia lands second Sputnik ...

5 years ago

Bayer plots a major facelift at Berkeley campus, uncorking a 30-year, $1.2B plan to drive cell and gene therapies

5 years ago

LLS backs 5 new cancer drug projects with up to $50M; Trodelvy continues to impress with more TNBC data

5 years ago

Radiopharma remains hot as Germany's ITM raises $109M to advance neuroendocrine cancer program

5 years ago

As Moderna rose, Flagship cashed in for $1.4B — with a lot more wealth still remaining

5 years ago

In a supply chain shortage workaround, Australia's Victoria state aims to build its own mRNA facility

5 years ago

Evotec strengthens its French connection, pledging to drop $120M into Toulouse plant for Covid-19 antibodies

5 years ago

Damn the critics, Biogen CEO Vounatsos orders full speed ahead on prepping a controversial aducanumab launch as FDA ...

5 years ago

Invitae sets up shop in North Carolina as part of plan to rapidly expand its genetic testing manufacturing

5 years ago

First page Previous page 703 704 705706707 708 709 Next page Last page